These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25494475)

  • 1. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report.
    Salpeter SR; Buckley JS; Buckley NS; Bruera E
    J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.
    Salpeter SR; Buckley JS; Bruera E
    J Palliat Med; 2013 Jun; 16(6):616-22. PubMed ID: 23556990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved?
    Cobos EJ; Baeyens JM
    J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
    Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
    J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
    Khoo SY; Aziz FA; Nambbiar P
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone Dose Selection for Treatment of Pain Compared with Consensus Recommendations.
    Karimian P; Atayee RS; Ajayi TA; Edmonds KP
    J Palliat Med; 2017 Dec; 20(12):1385-1388. PubMed ID: 28609231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
    Tse DM; Sham MM; Ng DK; Ma HM
    Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients.
    Fife A; Postier A; Flood A; Friedrichsdorf SJ
    J Opioid Manag; 2016; 12(2):123-30. PubMed ID: 27194197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone titration in opioid-resistant cancer pain.
    Scholes CF; Gonty N; Trotman IF
    Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.